NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT
CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.
CINCINNATI, May 07, 2018 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company”)
(TSXV:PHM), a healthcare services company with operations in the U.S., today announced that it has changed its name from “Patient
Home Monitoring Corp.” to “Protech Home Medical Corp.” and will commence trading under the new name at the market opening today.
The Company’s common shares will continue to trade under the symbol “PHM”.
Edward Brann has notified the Company he is leaving the Board to pursue other ventures. “We want to thank Edward
for his contributions and efforts, he has been a great asset during this transition. We will be looking to replace his role on the
Board” mentioned Mr. Crawford.
ABOUT PROTECH HOME MEDICAL
PHM provides in-home monitoring and disease management services for patients in the United States healthcare
market. It seeks to continue to expand its offerings and to use technology to dominant market share in certain regional markets,
through both acquisitions and taking market share directly from competitors, by deploying existing advanced logistics technologies
that provide faster and more reliable service for the patients.
The primary business objective of PHM is to create shareholder value by offering a broader range of services to
patients in need of in-home monitoring and chronic disease management. PHM's organic growth strategy is to increase market share in
its existing locations by making life easier on the patient, the rendering physician, and improving quality of care.
Forward-Looking Statements
Certain statements contained in this press release constitute "forward-looking information" as such term is
defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek",
"intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company,
including, the Company being confident its second quarter financials will be strong with both revenue and profit growth
compared to the first quarter, are intended to identify forward-looking information. All statements other than statements
of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with
respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and
assumptions, including, the results for second quarter known to date not materially changing. Many factors could
cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary
from those described herein should one or more of these risks or uncertainties materialize. Examples of such risk factors include,
without limitation: credit; market (including equity, commodity, foreign exchange and interest rate); liquidity; operational
(including technology and infrastructure); reputational; insurance; strategic; regulatory; legal; environmental; capital adequacy;
the general business and economic conditions in the regions in which the Company operates; the ability of the Company to execute on
key priorities, including the successful completion of acquisitions, business retention, and strategic plans and to attract,
develop and retain key executives; difficulty integrating newly acquired businesses; the ability to implement business strategies
and pursue business opportunities; low profit market segments; disruptions in or attacks (including cyber-attacks) on the Company's
information technology, internet, network access or other voice or data communications systems or services; the evolution of
various types of fraud or other criminal behavior to which the Company is exposed; the failure of third parties to comply with
their obligations to the Company or its affiliates; the impact of new and changes to, or application of, current laws and
regulations; decline of reimbursement rates; dependence on few payors; possible new drug discoveries; a novel business model;
dependence on key suppliers; granting of permits and licenses in a highly regulated business; the overall difficult litigation
environment, including in the U.S.; increased competition; changes in foreign currency rates; increased funding costs and market
volatility due to market illiquidity and competition for funding; the availability of funds and resources to pursue operations;
critical accounting estimates and changes to accounting standards, policies, and methods used by the Company; and the occurrence of
natural and unnatural catastrophic events and claims resulting from such events; as well as those risk factors discussed or
referred to in the Company’s disclosure documents filed with the securities regulatory authorities in certain provinces of Canada
and available at www.sedar.com. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the
forward-looking information prove incorrect, the actual results or events may differ materially from the results or events
predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the
Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking
information included in this press release is made as of the date of this press release and the Company undertakes no obligation to
publicly update or revise any forward-looking information, other than as required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information please visit our website at www.protechhomemedical.com, or contact:
Hardik Mehta
CFO
Protech Home Medical Corp.
859-300-6455
investorinfo@myphm.com
